Multiparameter diffusion-weighted imaging for characterizing pathological patterns in lupus nephritis patients: A preliminary study
Multiparameter diffusion-weighted imaging for characterizing pathological patterns in lupus nephritis patients: A preliminary study
复制标题
多参数弥散加权成像表征狼疮性肾炎患者的病理模式:初步研究
DOI:
10.1002/jmri.26657
复制
发表时间:
2019-10-01
影响因子:
4.4
通讯作者:
Suo, Shiteng
中科院分区:
文献类型:
--
作者:
Zhang, Shan;Lin, Yanwei;Suo, Shiteng
Background Microstructural changes of lupus nephritis (LN) kidney such as inflammatory cell infiltration or fibrosis could influence water molecular movement or diffusion, which indicates that diffusion-weighted imaging (DWI) may become a valuable tool in evaluation of this disease. Purpose To explore whether multiparameter diffusion-weighted imaging (mDWI) could contribute to characterize pathological patterns in LN patients. Study Type Retrospective. Population Twenty-two patients with LN. Field Strength/Sequence Multi-b value DWI was performed with a 3.0 T scanner. Assessment Apparent diffusion coefficient (ADC)(m), perfusion-related diffusion coefficient (D-f), molecular diffusion coefficient (D-s), perfusion fraction (f), ADC(s), alpha, ADC(k), and mean kurtosis (MK) were calculated by monoexponential, biexponential, stretched-exponential, and kurtosis models fits, respectively. Statistical Tests Independent sample t-test, Pearson analysis and receiver operating characteristic (ROC). Results In the whole group, the activity index (AI) correlated significantly with alpha values in the medulla (rho = -0.54, P = 0.03). The chronicity index (CI) correlated significantly with D-s values in the medulla (rho = -0.61, P = 0.02). No significant association was found between any other diffusion parameter and histologic grade with all P > 0.05. For differentiating proliferative LN (Class III or IV) from Class V, the area under the ROC curve (AUC) of alpha in the medulla was 0.833 (P = 0.023). Data Conclusion mDWI might be used for the characterization of pathological patterns in LN patients. Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2019;50:1075-1084.